Pen13
General Information
DRACP ID DRACP02542
Peptide Name Pen13
Sequence KIWFQNRRMKWKK
Sequence Length 13
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Cell-penetrating peptides
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
HeLa WT | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | 50% Cytotoxicity>1000 μM | MTS/PMS assay | 1 h | 1 |
Hemolytic Activity Human erythrocytes: HD50>128 μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C87H137N27O16S
Absent amino acids ACDEGHLPSTVY
Common amino acids K
Mass 206349
Pl 12.56
Basic residues 6
Acidic residues 0
Hydrophobic residues 4
Net charge 6
Boman Index -4931
Hydrophobicity -186.15
Aliphatic Index 30
Half Life
Mammalian: 1 hour
Yeast: 2 min
E.coli: 2 min
Extinction Coefficient cystines 11000
Absorbance 280nm 916.67
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23085001
Title Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure
Doi 10.1016/j.bbamem.2012.10.010
Year 2013
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_8800